Macquarie Group LTD Supernus Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

  • $83.5 Billion
  • Q3 2025

A detailed history of Macquarie Group LTD transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 2,531,537 shares of SUPN stock, worth $114 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,531,537
Previous 2,762,124 8.35%
Holding current value
$114 Million
Previous $87.1 Million 38.96%
% of portfolio
0.14%
Previous 0.11%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$31.45 - $47.79 $7.25 Million - $11 Million
-230,587 Reduced 8.35%
2,531,537 $121 Million
Q2 2025

Aug 14, 2025
BUY
$30.29 - $33.43 $1.89 Million - $2.09 Million
62,457 Added 2.31%
2,762,124 $87.1 Million
Q1 2025

May 15, 2025
BUY
$31.17 - $40.0 $2.21 Million - $2.83 Million
70,760 Added 2.69%
2,699,667 $88.4 Million
Q4 2024

Feb 14, 2025
SELL
$31.89 - $37.83 $95,351 - $113,111
-2,990 Reduced 0.11%
2,628,907 $95.1 Million
Q3 2024

Nov 14, 2024
SELL
$25.77 - $35.16 $1.23 Million - $1.68 Million
-47,899 Reduced 1.79%
2,631,897 $82.1 Million
Q2 2024

Aug 09, 2024
BUY
$25.99 - $33.85 $280,692 - $365,580
10,800 Added 0.4%
2,679,796 $71.7 Million
Q1 2024

May 14, 2024
SELL
$27.11 - $35.17 $1.86 Million - $2.42 Million
-68,720 Reduced 2.51%
2,668,996 $91 Million
Q4 2023

Feb 14, 2024
SELL
$22.72 - $29.68 $298,540 - $389,995
-13,140 Reduced 0.48%
2,737,716 $79.2 Million
Q3 2023

Nov 14, 2023
BUY
$27.57 - $32.91 $6.82 Million - $8.14 Million
247,398 Added 9.88%
2,750,856 $75.8 Million
Q2 2023

Aug 14, 2023
BUY
$29.91 - $38.73 $879,024 - $1.14 Million
29,389 Added 1.19%
2,503,458 $75.3 Million
Q1 2023

May 15, 2023
BUY
$34.93 - $42.03 $1.87 Million - $2.25 Million
53,535 Added 2.21%
2,474,069 $89.6 Million
Q4 2022

Feb 21, 2023
BUY
$31.09 - $37.88 $1.57 Million - $1.91 Million
50,414 Added 2.13%
2,420,534 $86.3 Million
Q3 2022

Nov 14, 2022
BUY
$28.79 - $35.41 $944,772 - $1.16 Million
32,816 Added 1.4%
2,370,120 $80.2 Million
Q2 2022

Aug 15, 2022
BUY
$25.33 - $34.25 $439,576 - $594,374
17,354 Added 0.75%
2,337,304 $67.6 Million
Q1 2022

May 16, 2022
BUY
$28.51 - $32.9 $4.23 Million - $4.89 Million
148,522 Added 6.84%
2,319,950 $75 Million
Q4 2021

Feb 11, 2022
BUY
$26.37 - $34.22 $905,994 - $1.18 Million
34,357 Added 1.61%
2,171,428 $63.3 Million
Q3 2021

Nov 12, 2021
BUY
$23.54 - $31.39 $27,023 - $36,035
1,148 Added 0.05%
2,137,071 $57 Million
Q2 2021

Aug 13, 2021
BUY
$26.72 - $33.19 $1.39 Million - $1.73 Million
52,205 Added 2.51%
2,135,923 $65.8 Million
Q1 2021

May 14, 2021
SELL
$24.15 - $31.45 $3.08 Million - $4.01 Million
-127,442 Reduced 5.76%
2,083,718 $54.6 Million
Q4 2020

Feb 16, 2021
BUY
$17.7 - $25.81 $2.83 Million - $4.13 Million
160,161 Added 7.81%
2,211,160 $55.6 Million
Q3 2020

Nov 13, 2020
BUY
$20.2 - $25.05 $3.62 Million - $4.49 Million
179,045 Added 9.56%
2,050,999 $42.7 Million
Q2 2020

Aug 11, 2020
BUY
$17.09 - $24.89 $2.46 Million - $3.58 Million
143,690 Added 8.31%
1,871,954 $44.5 Million
Q1 2020

May 15, 2020
BUY
$14.45 - $24.69 $3.21 Million - $5.49 Million
222,444 Added 14.77%
1,728,264 $31.1 Million
Q4 2019

Feb 14, 2020
BUY
$19.93 - $29.13 $3.66 Million - $5.34 Million
183,442 Added 13.87%
1,505,820 $35.7 Million
Q3 2019

Nov 14, 2019
BUY
$25.47 - $33.37 $6.2 Million - $8.12 Million
243,377 Added 22.56%
1,322,378 $36.3 Million
Q2 2019

Aug 14, 2019
BUY
$29.96 - $38.87 $2.54 Million - $3.3 Million
84,846 Added 8.53%
1,079,001 $35.7 Million
Q1 2019

May 15, 2019
BUY
$32.77 - $41.99 $8.1 Million - $10.4 Million
247,111 Added 33.08%
994,155 $34.8 Million
Q4 2018

Feb 15, 2019
BUY
$30.84 - $49.51 $5.51 Million - $8.85 Million
178,682 Added 31.44%
747,044 $24.8 Million
Q3 2018

Nov 15, 2018
BUY
$42.7 - $56.55 $24.3 Million - $32.1 Million
568,362 New
568,362 $28.6 Million
Q2 2018

Aug 14, 2018
SELL
$44.1 - $59.85 $3.47 Million - $4.72 Million
-78,795 Closed
0 $0
Q1 2018

May 11, 2018
SELL
$37.15 - $46.9 $889,482 - $1.12 Million
-23,943 Reduced 23.3%
78,795 $3.61 Million
Q4 2017

Feb 15, 2018
BUY
$36.4 - $42.6 $566,020 - $662,430
15,550 Added 17.84%
102,738 $4.09 Million
Q3 2017

Nov 08, 2017
BUY
$36.75 - $49.65 $3.2 Million - $4.33 Million
87,188
87,188 $3.49 Million

Others Institutions Holding SUPN

# of Institutions
332
Shares Held
60.2M
Call Options Held
234K
Put Options Held
0
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.41B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email